Product Launched Chemicals & Petrochemicals NSE: AVI ·

AVI Polymers Launches Ashwini Healthcare AI with 5,620 Users and ₹12 Cr ARR Target

NSE Filing 4 min read 2 views
AVI Polymers Launches Ashwini Healthcare AI with 5,620 Users and ₹12 Cr ARR Target

AVI Polymers Ltd — Product Launched · AVI

Baseline ARR

₹0.06 Cr

Year-1 Projection

Market Cap

₹217.34 Cr

Small Cap

Net Profit TTM

₹19.55 Cr

LTM Earnings

Day RSI

72.25

Overbought Zone

! Key Highlights

  • Registered a highly engaged waitlist of over 5,620 users during the soft launch phase
  • Annual subscription pricing set at ₹999 to drive deep penetration in the domestic retail market
  • Projected initial conversion of 600 to 900 active paying subscribers in the first year
  • Phase 1 growth milestone targets 10,000 paying subscribers to reach a ₹1 Crore ARR run-rate
  • Long-term Phase 2 roadmap aims for 1.20 lakh subscribers and up to ₹12 Crore ARR

AVI Polymers Ltd has officially introduced Ashwini Healthcare AI, a dedicated HealthTech SaaS platform that has already secured a waitlist of over 5,620 organic users. The company expects to convert this early interest into a recurring revenue stream with a baseline Year-1 Annual Recurring Revenue projected between ₹6.00 Lakhs and ₹9.00 Lakhs.

The Product — What It Is

Ashwini Healthcare AI is a cloud-native HealthTech platform accessible via the official portal at www.ashwini.tech. Engineered on a scalable Software-as-a-Service architecture, the platform provides AI-driven personal health insights by mirroring the unit economics and retention metrics found in premium global wearable and performance ecosystems. The interface is designed to integrate data from various health monitors to deliver actionable wellness intelligence to retail users.

This digital solution focuses on user stickiness through high-frequency engagement, targeting individuals looking for data-backed health management tools in the Indian market.

Commercial Opportunity

  • Conversion metrics for the initial cohort are modeled between 8% and 15% of the current waitlist
  • Subscription model ensures high gross margins by leveraging low-cost digital distribution
  • Phase 1 operational targets focus on achieving a ₹1 Crore ARR through 10,000 active users
  • Phase 2 institutional-grade scaling targets up to 1,20,000 subscribers to unlock Series-A valuation metrics
  • Internal operational targets aim for a 65% to 70% annual user retention rate

Strategic Pivot and Financial Context

This launch represents a significant strategic pivot for AVI Polymers from its traditional specialty chemicals background into high-visibility digital platforms. The move is designed to establish recurring revenue streams that are not tied to the cyclicality of chemical raw materials. Despite a recent decline in promoter holding to 1.1%, the company has demonstrated strong financial momentum with a net profit growth of 1278% YoY in the latest quarter.

The management intends to scale this SaaS roadmap to deliver compounded, debt-free growth by utilizing existing cash flows to fund digital expansion.

Industry Context

The Indian HealthTech and Wellness SaaS market is undergoing rapid expansion as consumers increasingly adopt digital-first preventive healthcare tools. AVI Polymers is entering a sector characterized by high entry barriers for effective AI modeling but significant rewards for platforms that can maintain high retention rates. By benchmarking its performance against global wearable ecosystems, the company aims to capitalize on the increasing penetration of affordable smartphones and high-speed data across domestic retail segments, where low-cost annual subscriptions are becoming the standard for premium wellness services.

AVI Polymers Ltd — Financial Snapshot

BSE: 539288 · NSE: AVI · Chemicals & Petrochemicals

Current Market Price ₹23.1 per share
Market Capitalisation ₹217.34 BSE Listed
Revenue (Annual) ₹312.11 Operating
Net Profit (Annual) ₹20.33 Consolidated
P/E Ratio (TTM) 11.11× Sector: 41.91×
Promoter Holding 1.1% -24.09% QoQ
FII Holding 0% Current Qtr

"We remain exceptionally confident in our ability to scale this SaaS roadmap and deliver compounded, debt-free growth to our shareholders."

— Chintan Yashwantbhai Patel, Managing Director

Source Verified

Exchange filing by AVI Polymers Ltd announcing the soft launch and early adoption metrics for Ashwini Healthcare AI. Financial metrics from Trendlyne.

View Filing